Replies to post #37878 on OncoSec Medical Inc (ONCSQ)

[Titan V]

I found this article:

Industry insists Australian clinical trials are internationally cost competitive contrary to 2012 report
http://www.fiercepharma.com/pharma/industry-insists-australian-clinical-trials-are-internationally-cost-competitive-contrary-to

If you consider that the Australian R&D tax incentive was not included in this report, currently being up to 45%, this alone would have placed Australia competitively with Russia. "Foreign entities can claim R&D Tax incentives (http://www.swansonreed.com.au/product/45-rebate-for-australian-rd-costs/) through their Australian subsidiaries at 45 cents in the dollar, that means $450,000 for $1,000,000 foreign spend in Australia", says Adam Rogers, R&D Tax specialist at Swanson & Reed.

Thanks again for your insights.